Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

170 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Results of the NRG Oncology/RTOG 0848 Adjuvant Chemotherapy Question-Erlotinib+Gemcitabine for Resected Cancer of the Pancreatic Head: A Phase II Randomized Clinical Trial.
Abrams RA, Winter KA, Safran H, Goodman KA, Regine WF, Berger AC, Gillin MT, Philip PA, Lowy AM, Wu A, DiPetrillo TA, Corn BW, Seaward SA, Haddock MG, Song S, Jiang Y, Fisher BJ, Katz AW, Mehta S, Willett CG, Crane CH. Abrams RA, et al. Among authors: gillin mt. Am J Clin Oncol. 2020 Mar;43(3):173-179. doi: 10.1097/COC.0000000000000633. Am J Clin Oncol. 2020. PMID: 31985516 Free PMC article. Clinical Trial.
Long-term results of a phase II trial of ultrasound-guided radioactive implantation of the prostate for definitive management of localized adenocarcinoma of the prostate (RTOG 98-05).
Lawton CA, Hunt D, Lee WR, Gomella L, Grignon D, Gillin M, Morton G, Pisansky TM, Sandler H. Lawton CA, et al. Int J Radiat Oncol Biol Phys. 2011 Sep 1;81(1):1-7. doi: 10.1016/j.ijrobp.2010.05.056. Epub 2011 Apr 4. Int J Radiat Oncol Biol Phys. 2011. PMID: 21470793 Free PMC article. Clinical Trial.
Establishing the feasibility of the dosimetric compliance criteria of RTOG 1308: phase III randomized trial comparing overall survival after photon versus proton radiochemotherapy for inoperable stage II-IIIB NSCLC.
Giaddui T, Chen W, Yu J, Lin L, Simone CB 2nd, Yuan L, Gong YU, Wu QJ, Mohan R, Zhang X, Bluett JB, Gillin M, Moore K, O'Meara E, Presley J, Bradley JD, Liao Z, Galvin J, Xiao Y. Giaddui T, et al. Radiat Oncol. 2016 May 4;11:66. doi: 10.1186/s13014-016-0640-8. Radiat Oncol. 2016. PMID: 27142674 Free PMC article. Clinical Trial.
Reirradiation of thoracic cancers with intensity modulated proton therapy.
Ho JC, Nguyen QN, Li H, Allen PK, Zhang X, Liao Z, Zhu XR, Gomez D, Lin SH, Gillin M, Komaki R, Hahn S, Chang JY. Ho JC, et al. Pract Radiat Oncol. 2018 Jan-Feb;8(1):58-65. doi: 10.1016/j.prro.2017.07.002. Epub 2017 Jul 8. Pract Radiat Oncol. 2018. PMID: 28867546
Quality of life and toxicity from passively scattered and spot-scanning proton beam therapy for localized prostate cancer.
Pugh TJ, Munsell MF, Choi S, Nguyen QN, Mathai B, Zhu XR, Sahoo N, Gillin M, Johnson JL, Amos RA, Dong L, Mahmood U, Kuban DA, Frank SJ, Hoffman KE, McGuire SE, Lee AK. Pugh TJ, et al. Int J Radiat Oncol Biol Phys. 2013 Dec 1;87(5):946-53. doi: 10.1016/j.ijrobp.2013.08.032. Epub 2013 Oct 15. Int J Radiat Oncol Biol Phys. 2013. PMID: 24139077 Free PMC article.
170 results